secwatch.observer — SEC 8-K summary
======================================

Issuer:     908 Devices Inc. (MASS)
CIK:        0001555279
Form:       8-K
Filed at:   2022-03-02T23:59:59+00:00
Accession:  0001104659-22-029353
Event type: leadership
Sentiment:  positive
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

908 Devices appoints Repligen CEO Tony J. Hunt to Board, effective March 2, 2022
--------------------------------------------------------------------------------

- Tony J. Hunt, President and CEO of Repligen (RGEN), appointed to Board expanding from 8 to 9 directors.
- Class II director with term expiring at June 2022 annual meeting; receives $40K annual cash retainer.
- One-time initial equity award of $200K (50% RSUs, 50% NQSOs) vesting over three years.
- Also eligible for future annual equity awards of $135K on same terms as other non-employee directors.
- Hunt brings over 20 years bioprocessing experience; previously President of Bioproduction at Life Technologies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1555279/000110465922029353/0001104659-22-029353-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1555279/000110465922029353/tm228064d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-029353

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer